Literature DB >> 27818269

Cannabinoid modulation of memory consolidation within the cerebellum.

Adam B Steinmetz1, John H Freeman2.   

Abstract

Cannabinoid receptors contribute to learning and synaptic plasticity mechanisms. The cerebellum contains a high density of cannabinoid receptors and manipulations of cannabinoid receptors affect synaptic plasticity within the cerebellar cortex. In vivo studies have found that cannabinoid agonists impair learning of cerebellum-dependent eyeblink conditioning in rodents and humans. However, the role of cannabinoid receptors or endocannabinoids in memory consolidation within the cerebellum has not been examined. In the current study, we examined the role of cannabinoid receptors and endocannabinoids during learning and consolidation of eyeblink conditioning in rats. Administration of the cannabinoid receptor agonist WIN55,212-2 or drugs that increase/decrease endocannabinoid levels directly into the cerebellar cortex before each training session resulted in marked learning impairments. When administered 1 h after each training session, during memory consolidation, the cannabinoid inverse agonist SR141716A or the endocannabinoid suppressor THL impaired memory. In contrast, increasing endocannabinoid levels with JZL-184 or infusion of WIN55,212-2 within the cerebellar cortex facilitated memory consolidation 1h post-training. Intracerebellar manipulations of cannabinoid receptors or endocannabinoid levels had no effect on memory consolidation when administered 3 or 6h after each training session. The results demonstrate that cannabinoids impair cerebellar learning, but facilitate memory consolidation mechanisms within the cerebellar cortex 1-3h after training. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  2-AG; Cannabinoid receptors; Cerebellum; Consolidation; Eyeblink conditioning

Mesh:

Substances:

Year:  2016        PMID: 27818269      PMCID: PMC5124493          DOI: 10.1016/j.nlm.2016.11.002

Source DB:  PubMed          Journal:  Neurobiol Learn Mem        ISSN: 1074-7427            Impact factor:   2.877


  34 in total

1.  Retention and extinction of delay eyeblink conditioning are modulated by central cannabinoids.

Authors:  Adam B Steinmetz; John H Freeman
Journal:  Learn Mem       Date:  2011-09-22       Impact factor: 2.460

2.  Climbing fiber-evoked endocannabinoid signaling heterosynaptically suppresses presynaptic cerebellar long-term potentiation.

Authors:  Boeke J van Beugen; Raghavendra Y Nagaraja; Christian Hansel
Journal:  J Neurosci       Date:  2006-08-09       Impact factor: 6.167

3.  Cerebellum: essential involvement in the classically conditioned eyelid response.

Authors:  D A McCormick; R F Thompson
Journal:  Science       Date:  1984-01-20       Impact factor: 47.728

Review 4.  Neural circuitry and plasticity mechanisms underlying delay eyeblink conditioning.

Authors:  John H Freeman; Adam B Steinmetz
Journal:  Learn Mem       Date:  2011-10-03       Impact factor: 2.460

5.  Determination and characterization of a cannabinoid receptor in rat brain.

Authors:  W A Devane; F A Dysarz; M R Johnson; L S Melvin; A C Howlett
Journal:  Mol Pharmacol       Date:  1988-11       Impact factor: 4.436

6.  Cellular mechanisms and behavioral consequences of Kv1.2 regulation in the rat cerebellum.

Authors:  Michael R Williams; Jason R Fuchs; John T Green; Anthony D Morielli
Journal:  J Neurosci       Date:  2012-07-04       Impact factor: 6.167

7.  Assessment of forebrain-dependent trace eyeblink conditioning in chronic cannabis users.

Authors:  Chad R Edwards; Patrick D Skosnik; Adam B Steinmetz; Jennifer M Vollmer; Brian F O'Donnell; William P Hetrick
Journal:  Neurosci Lett       Date:  2008-05-08       Impact factor: 3.046

8.  Cannabinoid receptor localization in brain.

Authors:  M Herkenham; A B Lynn; M D Little; M R Johnson; L S Melvin; B R de Costa; K C Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

9.  Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory.

Authors:  Patrizia Campolongo; Benno Roozendaal; Viviana Trezza; Daniela Hauer; Gustav Schelling; James L McGaugh; Vincenzo Cuomo
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-02       Impact factor: 11.205

10.  Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study.

Authors:  M Herkenham; A B Lynn; M R Johnson; L S Melvin; B R de Costa; K C Rice
Journal:  J Neurosci       Date:  1991-02       Impact factor: 6.167

View more
  6 in total

1.  Bidirectional short-term plasticity during single-trial learning of cerebellar-driven eyelid movements in mice.

Authors:  Farzaneh Najafi; Javier F Medina
Journal:  Neurobiol Learn Mem       Date:  2019-10-11       Impact factor: 2.877

2.  Intracerebellar cannabinoid administration impairs delay but not trace eyeblink conditioning.

Authors:  Adam B Steinmetz; John H Freeman
Journal:  Behav Brain Res       Date:  2019-09-24       Impact factor: 3.332

Review 3.  Cannabinoid agonist administration within the cerebellar cortex impairs motor learning.

Authors:  Adam B Steinmetz; John H Freeman
Journal:  Neurobiol Learn Mem       Date:  2018-06-30       Impact factor: 2.877

4.  Effects of Fatty Acid Amide Hydrolase Inhibitors Acute Administration on the Positive and Cognitive Symptoms of Schizophrenia in Mice.

Authors:  Marta Kruk-Slomka; Izabela Banaszkiewicz; Tomasz Slomka; Grazyna Biala
Journal:  Mol Neurobiol       Date:  2019-04-19       Impact factor: 5.590

5.  Cannabinoids modulate associative cerebellar learning via alterations in behavioral state.

Authors:  Catarina Albergaria; N Tatiana Silva; Dana M Darmohray; Megan R Carey
Journal:  Elife       Date:  2020-10-20       Impact factor: 8.140

6.  Differential effects of two early life stress paradigms on cerebellar-dependent delay eyeblink conditioning.

Authors:  Alexandra B Moussa-Tooks; William P Hetrick; John T Green
Journal:  Neurobiol Stress       Date:  2020-07-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.